Clinical Trial Update: Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population

View source ↗

Summary

A clinical trial update comparing asthma-related outcomes and costs in pediatric patients treated with fluticasone propionate, budesonide, or montelukast in a l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Flovent (fluticasone propionate)
• Pulmicort (budesonide)
• SINGULAIR (montelukast)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Status: COMPLETED | Results posted: 2011-05-05